 |
 |
 |
 |
|
 |
Treatment
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Phase I Study of MK-0752, a Notch Inhibitor, in Patients With Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors |
 |
San Francisco, CA |
 |
04/12/2010 |
 |
 |
 |
 |
 |
Details |
 |
ABTC09-04 - A Biomarker and Phase II Study of GDC-0449 in Patients with Recurrent Glioblastoma Multiforme |
 |
San Francisco, CA |
 |
04/12/2010 |
 |
 |
 |
Details |
 |
A Phase II study of Bevacizumab (Avastin) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
 |
 |
Details |
 |
ABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
Details |
 |
CERN08-02 - A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal Cord Ependymoma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
Details |
 |
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
 |
San Francisco, CA |
 |
07/07/2009 |
 |
 |
 |
 |
 |
Details |
 |
PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme |
 |
San Francisco, CA |
 |
07/07/2009 |
 |
 |
 |
Details |
 |
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas |
 |
San Francisco, CA |
 |
04/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Trial of RAD001 in Patients with Recurrent Low Grade Glioma |
 |
San Francisco, CA |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
 |
San Francisco, CA |
 |
01/17/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of Temozolomide (temodar) in the Treatment of Adult Patients with
Supratentorial Low Grade Glioma |
 |
San Francisco, CA |
 |
10/03/2007 |
 |
 |
 |
Details |
 |
Phase II Study of Temozolomide in Patients With Supratentorial Low-Grade Glioma |
 |
San Francisco, CA |
 |
05/02/2006 |
 |
 |
 |
 |
 |